On June 3, 2024, Madryn Health Partners (Cayman Master), LP, an entity affiliated with Madryn Asset Management, provided notice to Standard BioTools Inc that it has irrevocably withdrawn its March 15, 2024 notice of its intent to nominate director candidates and submit a business proposal at the Company?s upcoming 2024 annual meeting of stockholders, as described in the Company?s definitive proxy statement filed with the U.S. Securities and Exchange Commission on May 21, 2024. The Company intends to distribute to stockholders a revised proxy card reflecting such withdrawal.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.855 USD | +5.40% |
|
-0.54% | -16.29% |
01/07 | Declaration of Voting Results by Standard BioTools | CI |
01/07 | Standard BioTools Inc.(NasdaqGS:LAB) added to Russell Small Cap Comp Value Index | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.29% | 651M | |
+2.81% | 205B | |
+6.52% | 179B | |
+32.59% | 158B | |
+33.16% | 113B | |
+4.87% | 64.93B | |
+23.87% | 56.51B | |
-2.92% | 46.36B | |
-6.39% | 37.07B | |
+2.69% | 36.12B |
- Stock Market
- Equities
- LAB Stock
- News Standard BioTools Inc.
- Madryn Asset Management Issues a Notice to Standard BioTools